Company Presentation
Medivo Utilizes Lab Data to Improve Health
Medivo finds my patients, reaches
out to them, and makes sure they
have the right lipid panel
information so that when they come
in to see me, I can make the best
treatment decisions for them.
– Dr. Safirstein,
Cardiologist from New Jersey
“
”
Our Data
Analytics and
Intervention
Platform Helps:
• Physicians and Payers to track and improve patient
outcomes: population-based & detailed
• Patients to monitor their health via tools and clinical insights
• Life science clients to target, measure and message to
Overview: Snapshot
● $15M
– Series B – June 2013● $7M
– Series A – Late 2011● $750K
– Angel Round 2010● Key Clients
– Life Sciences Cos
– Health plans
● Key Partners
– Clinical Labs
– Providers
● HIPAA Compliant
● Private Cloud
Analytics Platform
● SSAE 16 II Certified
● Located in
● Founded in 2010
Key Employees
Drives 70% of clinical decisions
Growing role of companion diagnostics
in therapy selection
Lab market is extremely fragmented
Comprises 2% of overall healthcare
costs
Why Lab Data Analytics?
Great measure of quality and
outcomes
Convergence of diagnostics
and therapeutics
Empowers consumers
Testing is 50%-60% underutilized due
to gaps in care
2012 – Referenced from Forrester Research, etc.
Overview: Market Opportunity – U.S.
The healthcare analytics market is estimated to grow at 23.7% from 2012 to 2017 to reach $10.8 billion.1
1 Source – RNR Market Research
0
20
40
2012
2017
In Bil li on s2012
2017
Pharma
Marketing
14
20
Healthcare
Analytics
3.7
10.7
(in Billions)3M+ Patients
3,500 Practices >15K Providers
Medivo Lab Value Exchange
Data Sources
• National, Regional, Specialty labs • >100 labs
Medivo Lab Value Exchange
Life Science Companies
Payers
Data Aggregation and Harmonization
2012 – Referenced from Forrester Research, etc.
Ability to aggregate and normalize lab
data from multiple sources. “Experts” in
all things lab data.
Search appliance for direct access to
patient lab results across multiple
platforms. “Google search” of lab
results.
Proprietary algorithms to
identify care gaps. Analytics
engine to drive
improvement in care.
Medivo Lab Data Analytics Platform
Clinical Alerts & Messaging
Lab Results Search Utility
Platform: Provider Satisfaction with Medivo
• • •
Keep up the great work, and thank you for making my patient care and disease
tracking a lot easier
The information provided by Medivo is very valuable
Provider acquisition cost < $100
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 65OVER 55-64 45-54 35-44 22-34 21UNDER
Growth in Identified Patients w/Clinical Data
Platform: Lab Data Access for Patients
Revenue: Clinical Data and Analytics
An aly ze Diabetes Patient Identification Algorithm May Include • Dx Code: T2DM • > 2 HgA1c in 12 months = Diabetic • HgA1c > 7.0 & > 3 months = Gap • Fasting Glucose > 127 & no HgA1c = Gap • Random Glucose > 200 & no HgA1c = Gap
200K Physicians
>50M Patients
Financials: P&L and Bookings Projections
($'s in 000's) Actual Projected - Year Ended Decem ber 31,2011 2012 2013 2014 2015 2016 2017 Clinical data, analytics, & messaging 184 1,815 5,107 9,353 23,745 41,943 60,179 Clinical services 2,414 2,832 3,336 4,243 7,406 14,601 26,872 Total Revenues 2,598 4,647 8,442 13,596 31,151 56,544 87,051 Direct cost of sales 517 1,642 3,302 5,700 9,554 15,932 24,006 Gross profit 2,081 3,005 5,140 7,896 21,597 40,611 63,045 Operating expenses
Research & development 284 1,040 1,997 3,573 4,413 5,090 5,784 Sales & marketing 1,012 2,502 3,167 4,996 7,583 10,776 13,561 Operations 270 874 3,391 5,503 7,097 8,502 9,779 General & administrative 1,567 2,172 2,729 3,265 4,057 4,682 5,297 Total operating expense 3,133 6,587 11,284 17,337 23,151 29,050 34,421 EBITDA (1,052) (3,583) (6,143) (9,441) (1,554) 11,561 28,624
Data
Sources/Patient Growth
25M 50M 75M 100M
EHRs Pilots Top EHRs
Rx / Claims Data Surescripts Emdeon National Pharmacies HIEs Regional Pharmacies Apps/Devices Medivo Apps Third Party Apps Quantified Self Apps/Devices Healthcare Data Layer Lab Connectivity National Select Regionals Hubs Additional Hubs Specialty Additional Specialty
Strategy: Expansion
Comparisons Focused on Acquired by
Medicity HIE Solutions Aetna for $500M
Axolotl
HIE Solutions Ingenix for around $140M (8X Revs)
dbmotion
Data Analytics Allscripts for $235M
Humedica
Data Analytics UnitedHealth (optum)
$150-200M
Conclusion
● Proven Leadership Team
– Strong leadership team with a track record
– Strategic and medical advisors add extensive health care and data
analytics experience
– Industry access and credibility
● Proven Business Model
– Proven and tested products
– Proven sales through key clients
– Strong revenue model
● Great Opportunity to Build Value
– Large market opportunity of >$15 billion
– Well positioned for fast growth, right services at right time
– 2-3% share can lead to $300 million to $500 million in revenues
THANK YOU!
● National, Regional, State ● Product/ Account
● Sales Force Aligned
● Ordering Account ● Provider Specialty ● Provider State and Zip ● Practice Size (where appropriate) ● Patient Demographics ● Payer (Medicare, Medicaid,
Commercial)
● Test gaps & anomalies
● Test Name ● Test Number
● Diagnostic Codes (ICD9) ● Normal Lab Range
● Lab Result (incl. code or symbol for abnormal results)
● Lab Test Service Date
